AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]
Real-World Evidence Alliance Online Read the Full Article>> Washington, D.C. (April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with[…]
Wed, Aug 18, 2021 2:00 PM – 3:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Automated, clinical ‘data networks’ are transforming the research paradigm. This webinar explores: – How do multi-purpose, ‘reusable’ data networks differ from the traditional research model, in particular for real-world evidence and patient registries? – How are data[…]
BOSTON, April 20, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, announced its Rheumatoid Arthritis (RA) registry now includes longitudinal clinical data from rheumatology specialists on more than 200,000 patients. OM1 also offers other specialty rheumatology registries, including Juvenile Idiopathic Arthritis (JIA), which has deep[…]
BOSTON, April 8, 2021 /PRNewswire/ — OM1, a real-world outcomes and technology company, today announced a strategic collaboration with the American Academy of Dermatology (AAD) connecting the Academy’s DataDerm™ clinical data registry to OM1’s real-world data and evidence platforms. The AAD estimates that 1 in 4 Americans (more than 85 million) see a physician for[…]
